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Abstract 
Background: To compare the results of 
percutaneous bone marrow aspirate injection with 
autologous bone grafting in the treatment of delayed 
union of femur and tibia diaphyseal fractures using 
Union Scale Score. 
Methods: In this randomized controlled trial 88 
patients with delayed diaphyseal fracture union of 
either tibia or femur were divided into two groups of 
44 patients each (Group A=bone marrow aspirate 
injections and Group B=autologous bone graft).The 
study outcome was assessed in terms of Union Scale 
Score after 6 weeks interval for 18 weeks time 
period.In Group A,the skin over iliac crest, about 2-4 
cm from anterior superior iliac spine was infiltrated 
with about 3 ml of 2% plain lignocaine. A bone 
marrow aspiration needle with multiple distal holes 
was inserted between the two tables of iliac bone.  
Twenty ml  bone marrow was aspirated. The needle 
was then replaced with a 16 gauge spinal needle and 
the BMA was injected in the vicinity of fracture 
site(non-union) under fluoroscope guidance. The 
recipient site was then sealed with band aid. In 
Group B, autogenous iliac bone graft taken by 
standard technique under general anaesthesia was 
harvested into the fracture site and immobilized by 
plaster of Paris cast where indicated. Fracture site 
mobility, tenderness and radiological features were 
assessed using the Union Scale Score in which union 
was considered with a score of 6 or more. In case of 
non-union, a secondary procedure was performed. 
Results: At 18 weeks follow-up, 70.4% cases in 
percutaneous bone marrow group and 93.2% in 
autologous bone graft group had achieved union 
scale score of 6 or above, though this difference was  
significant (p-value, 0.01). 
Conclusion: Percutaneous bone marrow aspirate 
injection is an effective alternative to autologous 
bone grafting for the treatment of delayed union of 
long bone fractures. 
Key Words: Delayed union, Autologous bone 
grafting, Percutaneous bone marrow aspirate (BMA), 
Bone mesenchymal stem cells (BMSC) 
Introduction 
Fracture union is a complex and well-orchestrated 
physiological process and takes several years for bone 
to regain its original structure and function.1,2 An array 
of cytokines and signaling proteins control this 
complex physiological process.3 A complete union can 
be described as clinically having no pain, tenderness 
and radiographically, as solid cortical callus having 
bridged both fragments.4 
Delayed bone union, accounting for 5-10% of all 
fractures,5 seriously affects physical and mental health 
of the patient and pose a major challenge for 
orthopaedic surgeons . In spite of all advances in 
treatment, results in additional financial burden on 
health care system and morbidity for the patient.6 
The US Food and Drug Administration (FDA) 
described fracture non-union as “a non-union is 
established after minimum of nine months time period 
has passed since fracture and there is no progressive 
visible radiological evidence of healing for a period of 
approximately three months.”Delayed union is 
defined as un-united fracture that continues to show 
progress towards healing or that have not been present 
for long enough to satisfy the definition of non-
union.7The non union of closed tibial shaft fracture is 
prevalent in 2.5% individuals and increases 5-7 fold in 
case of open fractures with considerable soft tissue 
damage.8 
Autologous bone grafting possesses osteoconductive, 
osteoinductive and osteogenic cell components, 
thereby making it the “gold standard” treatment for 
fracture healing.9 Infection, painful scar, hematoma 
formation, anaemia and gait disturbance are some of 
the complications of this invasive procedure. Recent 
research has focused on the effectiveness of less 
invasive procedures so as to achieve similar results 
with fewer side effects.10,11 
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Bone marrow aspirate is an effective source of 
mesenchymal stem cells and osteoprogenitor cells 
which in turn are the most important factors in process 
of bone formation and healing of delayed union. It also 
has the additional advantage of being minimal 
invasive, relatively safer, simpler, economical and 
short duration procedure.12 
Herzog introduced percutaneous bone grafting for the 
first time in 1951 with the use of large bore needle and 
small cancellous chips to graft a non union.13 Connolly 
reported the results of autogenous bone marrow 
injections in treating 20 tibia fracture non-unions over 
a period of five years and achieved union of 18/20 
cases (90%).14 
Keeping in mind the considerable high influx of 
patients in emergency and outpatient departments of 
our tertiary care public hospitals like Pakistan Institute 
of Medical Sciences, Islamabad, sound case load 
management with limited resources and time 
constraints is always a challenge. Therefore, efficacy of 
this novel and simple technique was evaluated.  
 
Patients and Methods 
A randomized controlled trial was conducted at the 
Department of Orthopedic Surgery, Pakistan Institute 
of Medical Sciences, Islamabad for a period of eight 
months between May 2016 to January 2017.Sample 
size was calculated with the help of WHO calculator 
which turned out to be 88 patients with delayed 
diaphyseal fracture union of either tibia or femur and 
was divided into two groups of 44 patients each 
(Group A=bone marrow aspirate injection, Group 
B=autologous bone graft). Patient’s inclusion criteria 
included age between 18 to 60 years, duration of 
fracture more than 12 weeks, abnormal mobility at the 
fracture site, tenderness at the fracture site and pain on 
applying bending stress. Patients were excluded if 
they were pregnant females (they can not be exposed 
to radiations of image intensifier), infected 
cases,pathological fractures or had established non 
union. 
The study outcome was assessed in terms of Union 
Scale Score (Table 1) after 6 weeks interval for 18 
weeks time period.In Group A,the skin over iliac crest, 
about 2-4 cm from anterior superior iliac spine was 
infiltrated with about 3 ml of 2% plain lignocaine. A 
bone marrow aspiration needle with multiple distal 
holes was inserted between the two tables of iliac 
bone. To minimize aspirating air into the syringe, it 
was ensured that all distal holes were well beyond  
 
cortical wall. Twenty  cc bone marrow was aspirated 
and site was sealed with a sterile tape. The needle was 
then replaced with a 16 gauge spinal needle and the 
BMA  injected in the vicinity of fracture site(non-
union) under flouroscope guidance. The recipient site 
was then sealed with band aid.In Group B,autogenous 
iliac bone graft taken by standard technique under 
general anesthesia was harvested into the fracture site 
and immobilized by plaster of Paris cast where 
indicated.Patients of both groups were called at 
interval of six weeks for four months. Fracture site 
mobility, tenderness and radiological features were 
assessed using the Union Scale Score in which union 
was considered with a score of 6 or more. In case of 
non-union, a secondary procedure was performed.The 
final functional outcome as per Union Scale Score was 
compared among the study groups using chi-square 
test at 6, 12 and 18 weeks. A p-value of <0.05 was 
considered significant.  
 
Table 1: Union Scale Score4 – Maximum Score 7. 
Features 0 1 2 3 
Mobility  Frank 
mobility 
in both 
planes 
Restricted 
mobility in 
both planes 
Minimum 
mobility in 
one plane 
No 
mobility 
at all 
Tenderness  Present  Absent    
Radiological 
features 
No callus 
at all 
Minimum 
ensheathing 
callus 
Good 
ensheathing 
callus or 
internal 
callus with 
bridging of 
at least two 
cortex 
Good 
internal 
callus 
with 
bridging 
of all 
four 
cortex 
 
Results 
Male cases were in majority in both study groups. The 
mean age was slightly younger in bone marrow group 
compared to bone graft group (31.2 vs 37.3 years 
respectively)(Table  2). At 18 weeks follow-up, the 
mean Union Scale Score was found slightly less in 
autologous bone marrow aspirate group than 
autologous bone graft group (5.9 vs 6.6) (Table 3). At 
18 weeks follow-up, 31 (70.4%) cases in percutaneous 
bone marrow group and 41 (93.2%) in autologous bone 
graft group had achieved union scale score of 6 or 
above, though this difference was significant (p-value, 
0.01) but overall the success rate of both procedures 
was quite high making a case for usage of 
percutaneous bone marrow grafting as a comparable 
alternative treatment modality (Table 4) 
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Table 2: Distribution of gender and age of 
patients in the two study groups 
 Percutaneous bone marrow 
group (n=44) 
Autologous bone graft  
group (n=44) 
Gender 
  Male  38 (86.4%) 36 (81.8%) 
  Female 6 (13.6%) 8 (18.2%) 
Age (years) 
  Mean ± SD 31.2 ± 10.5 37.3 ± 13.7 
Table 3: Comparison of Union Scale Score 
between the two groups 
 Percutaneous bone 
marrow group  
(n=44) 
Autologous bone 
graft group  
(n=44) p-value 
Initial 
  1 0 (0.0%) 3 (6.8%) 
0.01 
  2 3 (6.8%) 4 (22.7%) 
  3 8 (18.2%) 14 (31.8%) 
  4 15 (34.1%) 18 (40.9%) 
  5 18 (40.9%) 5 (11.4%) 
At 6 weeks 
  3 3 (6.8%) 0 (0.0%) 
0.32 
  4 6 (13.6%) 9 (20.5%) 
  5 19 (43.2%) 23 (52.3%) 
  6 14 (31.8%) 11 (25.0%) 
  7 2 (4.5%) 1 (2.3%) 
At 12 weeks 
  3 3 (6.8%) 0 (0.0%) 
0.10 
  4 0 (0.0%) 0 (0.0%) 
  5 16 (36.4%) 10 (22.7%) 
  6 13 (29.5%) 15 (34.1%) 
  7 12 (27.3%) 19 (43.2%) 
At 18 weeks 
  3 3 (6.8%) 0 (0.0%) 
0.01 
  4 0 (0.0%) 0 (0.0%) 
  5 10 (22.7%) 3 (6.8%) 
  6 13 (29.5%) 11 (25.0%) 
  7 18 (40.9%) 30 (68.2%) 
Discussion 
Bone marrow, because of having great osteogenic 
properties, has already been widely used as bone graft 
substitute in basic research and clinical practice.5 Bone 
mesenchymal stem cells within the bone marrow play 
the pivotal role in the process of bone formation.15,16 
Under the stimulation of bone induction signal, 
BMSCs proliferate and differentiate into osteoblasts, 
chondrocytes and adipose cells.17According to 
multiple studies, better healing rate and lesser time 
needed for union could be achieved by concentrating 
the aspirated bone marrow with centrifuge machine.18-
21 
However, in our study, the bone marrow aspirate 
taken from the iliac crest was directly injected into the 
delayed union site. It was witnessed that more than 
90% of the cases in the autologous bone grafting group 
achieved Union Scale Score of 6 or above at 18 weeks 
post treatment, whereas more than 70% in 
percutaneous bone marrow group achieved union 
after the same treatment period. The results were 
comparable with 88.3% reported in the study by 
Hernigou et al22 in 2006 and 76% reported in the study 
by Sugaya et al.18Wani et al also reported that 75% of 
their non-union cases who were given percutaneous 
bone marrow, succeeded in achieving union after a 
mean period of 18.4 weeks.6 
Elsattar et al witnessed 80% union achievement after 
autologous bone marrow injection.23Ahmed A and 
colleagues from Lahore reported that more than 80% 
of their cases achieved union after percutaneous bone 
marrow injection and they concluded that 
percutaneous bone marrow is an alternate option for 
patients with non-union of long bone 
fractures.24Lamture DR et al reported that autologous 
bone marrow graft is the choice of treatment in non-
union fractures.25These findings are comparable to our 
study. Kassem et al assessed percutaneous bone 
grafting and found that it was able to achieve union in 
95% cases.1There is scientific evidence7,12,13,24 
suggesting the success of percutaneous bone marrow 
injection and its nearly similar effectiveness to 
autologous bone grafting makes it a perfect alternate. 
On the other hand, autologous bone grafting technique 
is more costly, time consuming, requires general 
anaesthesia and has numerous donor and recipient site 
side effects like painful scar, infections, hematoma 
formation, anaemia and gait disturbance.26Acute and 
chronic donor site pain, affecting up to 60% of patients 
after iliac crest cancellous bone graft procedure has 
been reported.27Furthermore, the opening of recipient 
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site adds devascularisation risk which is damaging for 
an already impaired healing process.4,7 
There are other non-operative methods as well,which 
are performed by using low intensity ultrasound, 
electrical stimulation and electromagnetic stimulation. 
These procedures are sometimes tedious, time 
consuming, require sophisticated equipment and 
expertise. Search for a safe, economical and easy 
treatment technique for delayed union of fractures was 
always there and percutaneous bone marrow injection 
provides all these benefits. Additionally, aspirated 
bone marrow injection has also proven to jump start 
callus formation by increasing the regenerative 
potential where autologous bone grafting showed 
slow progress.28 
Excellent follow up and methodological rigor are key 
strengths of our study. Although the number of 
patients (n=88) evaluated in our study is greater than 
the limited count of local studies conducted on the 
outcome of percutaneous bone marrow injection 
technique in our population, continuation of data 
collection in multi-centric studies with long term 
functional outcome is need of the hour,so as to further 
delineate the utility of this technique.29 Nevertheless, 
the proposed technique exhibited slightly inferior 
results than the current gold standard. The 
management of increased number of patients with 
limited resources, safety of procedure, lesser time in 
hospital and decreased complication rate surely 
outweigh the other aspects.  
 
Conclusion 
Percutaneous bone marrow aspirate injection is 
simple, economical and efficacious alternative to 
autologous bone grafting for the treatment of delayed 
union of long bone fractures. 
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